Home  »  Markets   »  Cognition Therapeutics Inc. (CGTX) Review – ...

Cognition Therapeutics Inc. (CGTX) Review – Making Smarter Decisions

Cognition Therapeutics Inc. (NASDAQ: CGTX) is -69.46% lower on its value in year-to-date trading and has touched a low of $1.07 and a high of $10.95 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The CGTX stock was last observed hovering at around $1.69 in the last trading session, with the day’s gains setting it 0.24%.

Currently trading at $1.93, the stock is 23.76% and 13.46% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.25 million and changing 14.20% at the moment leaves the stock -17.56% off its SMA200. CGTX registered -79.85% loss for a year compared to 6-month loss of -18.91%.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


The stock witnessed a 12.87% gain in the last 1 month and extending the period to 3 months gives it a -9.81%, and is 40.88% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 15.02% over the week and 14.95% over the month.

Distance from 52-week low is 80.37% and -82.37% from its 52-week high.

Cognition Therapeutics Inc. (CGTX) Analyst Forecasts

The EPS is expected to shrink by -24.90% this year

Cognition Therapeutics Inc. (CGTX) Top Institutional Holders

The shares outstanding are 22.84M, and float is at 21.24M with Short Float at 0.29%.

Cognition Therapeutics Inc. (CGTX) Insider Activity

A total of 2 insider transactions have happened at Cognition Therapeutics Inc. (CGTX) in the last six months, with sales accounting for 1 and purchases happening 1 times. The most recent transaction is an insider purchase by Ricciardi Lisa, the company’s CEO & President. SEC filings show that Ricciardi Lisa bought 12,000 shares of the company’s common stock on Nov 15 at a price of $1.30 per share for a total of $15600.0. Following the purchase, the insider now owns 24500.0 shares.

Cognition Therapeutics Inc. disclosed in a document filed with the SEC on Nov 15 that Wallace Peggy (Director) bought a total of 12,500 shares of the company’s common stock. The trade occurred on Nov 15 and was made at $1.20 per share for $15000.0. Following the transaction, the insider now directly holds 37961.0 shares of the CGTX stock.

Most Popular

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Related Posts

Receive Best Stock To Trade Before The Opening Bell



100% Free. Stop Anytime. No Spam




The 5 Best Inflation Stocks for 2022

100% free. stop anytime no spam

Get our free report on the stocks that we recommend for investors who want to protect their portfolios from inflation.